Currently, the edge-to-edge leaflet repair device is the only recommended intervention to treatÂ MR, but there are many emerging technologies, including but not limited to neo-cords, transcatheter mitral valve repair, and rings. At present, the following are the indications

- Moderate to severeÂ primary MR (3 to 4+)

- Moderate to severe secondary MR (3 to 4+)

- Symptomatic heart failure

- High or prohibitive risk for surgery

- FavorableÂ anatomy

- Life expectancy >1 year